Project description
Boosting nervous system repair and regeneration in mammals
The mammalian central nervous system (CNS) is an intricate and fragile structure that has a limited capacity to self-repair after injury. Neural stem cells in the mammalian CNS lack the gene regulatory circuits that dictate when and where to activate developmental gene expression for regeneration. Consequently, most of the cells lost to injury are never replaced. The ERC-funded EnhanceRegen project will carry out research to uncover the basic principles of gene regulation after CNS injury. Relying on advanced technologies, researchers will identify injury-responsive elements in the spinal cords of mice. Machine learning will aid them in decoding the rules of injury-sensing DNA elements. This will open new avenues for the design of smart gene therapies using synthetic regeneration enhancers.
Objective
The mammalian central nervous system (CNS) is the epitome of complex cellular architecture. Still, it has a limited capacity to self-repair after an injury, which contrasts with the regenerative potential of the CNS in lower vertebrates. Regeneration unfolds by the orchestrated triggering of developmental gene expression programs after injury. These programs are under the control of dedicated regeneration enhancer elements, which grant adult cells transcriptional access to developmental genes. Neural stem cells in the mammalian CNS lack the gene regulatory circuits that dictate when and where to activate the expression of developmental genes for regeneration. Consequently, most of the cells lost to injury are never replaced.
This proposal aims to rewire mammalian gene expression circuits to endow neural stem cells with the capacity to activate regenerative responses after injury.
First, building on innovative technologies, some of which that I developed, we will identify injury-responsive enhancer elements in the mouse spinal cord with single cell and spatiotemporal resolution. Then, using machine learning, we will decode the rules of injury-sensing DNA elements to design synthetic injury-responsive enhancers for precise gene expression control in neural stem cells. Finally, we will use synthetic enhancers in therapeutically relevant gene delivery systems to rewire gene circuits in order to promote the recruitment resident stem cells for cell replacement through the reactivation of developmental genes that would otherwise remain silent.
The proposed research will uncover basic principles of gene regulation after CNS injury and open new avenues for the design of smart gene therapies for regenerative medicine using synthetic regeneration enhancers.
Fields of science
- natural sciencesbiological sciencesneurobiology
- medical and health sciencesmedical biotechnologygenetic engineeringgene therapy
- natural sciencesbiological sciencesgeneticsDNA
- medical and health sciencesmedical biotechnologycells technologiesstem cells
- natural sciencescomputer and information sciencesartificial intelligencemachine learning
Programme(s)
- HORIZON.1.1 - European Research Council (ERC) Main Programme
Topic(s)
Funding Scheme
ERC - Support for frontier research (ERC)Host institution
17177 Stockholm
Sweden